NCT00590954 2020-10-19Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant GliomasMemorial Sloan Kettering Cancer CenterPhase 2 Completed32 enrolled 8 charts